Cytochrome P450 Activity in Ex Vivo Cornea Models and a Human Cornea Construct.
暂无分享,去创建一个
[1] F. Guengerich,et al. Contributions of human enzymes in carcinogen metabolism. , 2012, Chemical research in toxicology.
[2] A. Mitra,et al. Drug Delivery to the Eye , 2005 .
[3] N. V. van Haeringen,et al. Corneal Aldehyde Dehydrogenase, Glutathione Reductase, and Glutathione S-Transferase in Pathologic Corneas , 1993, Cornea.
[4] G. Putterman,et al. Lack of metabolism of timolol by ocular tissues. , 1985, Journal of ocular pharmacology.
[5] S. Reich,et al. Entwicklung eines organotypischen Korneakonstruktes als ein In-vitro-Modell für Permeationsstudien , 2001, Der Ophthalmologe.
[6] J. Masferrer,et al. Cytochrome P450 dependent metabolism of arachidonic acid in bovine corneal epithelium. , 1985, Biochemical and biophysical research communications.
[7] T. Leff,et al. Regulation of cytochrome P450 in cultured human colonic cells. , 1993, Archives of biochemistry and biophysics.
[8] H. Kautiainen,et al. Ophthalmic timolol in a hydrogel vehicle leads to minor inter-individual variation in timolol concentration in aqueous humor. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[9] M. Prausnitz,et al. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. , 1998, Journal of pharmaceutical sciences.
[10] Stephan Reichl,et al. Development of a serum-free human cornea construct for in vitro drug absorption studies: the influence of varying cultivation parameters on barrier characteristics. , 2010, International journal of pharmaceutics.
[11] S Reichl,et al. Cultivation and characterization of a bovine in vitro model of the cornea. , 2004, Die Pharmazie.
[12] L. Meyer,et al. Esteraseaktivität eines organotypischen humanen Kornea-Konstrukts (HCC) als In-vitro-Modell für Permeationsuntersuchungen , 2005, Der Ophthalmologe.
[13] S. Yamamoto,et al. Purification and cDNA cloning of human liver CYP4A fatty acid omega-hydroxylase. , 1994, Journal of biochemistry.
[14] D. Nebert,et al. Genetic differences in drug metabolism associated with ocular toxicity. , 1982, Environmental health perspectives.
[15] S. Coupland,et al. Hydrolases of anterior segment tissues in the normal human, pig and rat eye: a comparative study , 1994, Graefe's Archive for Clinical and Experimental Ophthalmology.
[16] Stephan Reichl,et al. Human cornea construct HCC-an alternative for in vitro permeation studies? A comparison with human donor corneas. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[17] J. Falck,et al. Hypoxia stimulates the synthesis of cytochrome P450-derived inflammatory eicosanoids in rabbit corneal epithelium. , 1998, The Journal of pharmacology and experimental therapeutics.
[18] Stephan Reichl,et al. In vitro cell culture models to study the corneal drug absorption , 2011, Expert opinion on drug metabolism & toxicology.
[19] Stephan Reichl,et al. Cell culture models of the human cornea — a comparative evaluation of their usefulness to determine ocular drug absorption in‐vitro , 2008, The Journal of pharmacy and pharmacology.
[20] A. Urtti,et al. Culture model of human corneal epithelium for prediction of ocular drug absorption. , 2001, Investigative ophthalmology & visual science.
[21] J. Hochman,et al. Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. , 1996, Drug metabolism and disposition: the biological fate of chemicals.
[22] David J. Liu,et al. Luminogenic cytochrome P450 assays , 2006, Expert opinion on drug metabolism & toxicology.
[23] Stephan Reichl,et al. Prevalidation of a human cornea construct as an alternative to animal corneas for in vitro drug absorption studies. , 2012, Journal of pharmaceutical sciences.
[24] Stephan Reichl,et al. Toward the practical implementation of eye-related bioavailability prediction models. , 2014, Drug discovery today.
[25] M. Engelke,et al. A Human Corneal Equivalent Constructed from SV40-immortalised Corneal Cell Lines , 2005, Alternatives to laboratory animals : ATLA.
[26] H. Handa,et al. An SV40-immortalized human corneal epithelial cell line and its characterization. , 1995, Investigative ophthalmology & visual science.
[27] V. Rogiers,et al. Effect of epidermal growth factor in collagen gel cultures of rat hepatocytes. , 1999, Toxicology in vitro : an international journal published in association with BIBRA.
[28] H. Shichi,et al. Enzymes of mercapturate synthesis and other drug-metabolizing reactions-specific localization in the eye. , 1981, Experimental eye research.
[29] W M Petroll,et al. Epithelial and corneal thickness measurements by in vivo confocal microscopy through focusing (CMTF). , 1997, Current eye research.
[30] F. Guengerich,et al. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. , 2001, Chemical research in toxicology.
[31] Tao Zhang,et al. Drug Transporter and Cytochrome P450 mRNA Expression in Human Ocular Barriers: Implications for Ocular Drug Disposition , 2008, Drug Metabolism and Disposition.
[32] V. Vasiliou,et al. Human aldehyde dehydrogenase 3A1 (ALDH3A1): biochemical characterization and immunohistochemical localization in the cornea. , 2003, The Biochemical journal.
[33] J. Masferrer,et al. Cytochrome P450, drug metabolizing enzymes and arachidonic acid metabolism in bovine ocular tissues. , 1987, Current eye research.
[34] C. Ehrhardt,et al. A Comparative Evaluation of Corneal Epithelial Cell Cultures for Assessing Ocular Permeability , 2008, Alternatives to laboratory animals : ATLA.
[35] O. Pelkonen,et al. Timolol Metabolism in Human Liver Microsomes Is Mediated Principally by CYP2D6 , 2007, Drug Metabolism and Disposition.
[36] Barry C. Jones,et al. DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS , 2004, Drug Metabolism and Disposition.
[37] A. Parkinson,et al. Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity. , 1996, Archives of biochemistry and biophysics.
[38] H. Shichi,et al. Cytochrome P450-mediated prostaglandin ωω-1 hydroxylase activities in porcine ciliary body epithelial cells , 1992 .
[39] Stephan Reichl,et al. Multidrug resistance-associated protein (MRP1, 2, 4 and 5) expression in human corneal cell culture models and animal corneal tissue. , 2014, Molecular pharmaceutics.
[40] Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1. , 1998 .
[41] J. Fogh,et al. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. , 1977, Journal of the National Cancer Institute.
[42] R. Ebel,et al. Temperature dependence of cytochrome P-450 reduction. A model for NADPH-cytochrome P-450 reductase:cytochrome P-450 interaction. , 1976, The Journal of biological chemistry.
[43] Stephan Reichl,et al. Expression analysis of MDR1, BCRP and MRP3 transporter proteins in different in vitro and ex vivo cornea models for drug absorption studies. , 2013, International journal of pharmaceutics.
[44] T. Aoyama,et al. Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. , 1991, Archives of biochemistry and biophysics.
[45] M. Schwartzman,et al. Hypoxia-induced production of 12-hydroxyeicosanoids in the corneal epithelium: involvement of a cytochrome P-4504B1 isoform. , 1999, The Journal of pharmacology and experimental therapeutics.
[46] A. Mitra,et al. Transport of acyclovir ester prodrugs through rabbit cornea and SIRC-rabbit corneal epithelial cell line. , 2001, Journal of pharmaceutical sciences.
[47] D. Waxman,et al. Use of 7-ethoxycoumarin to monitor multiple enzymes in the human CYP1, CYP2, and CYP3 families. , 1998, Methods in molecular biology.
[48] M. Schwartzman,et al. Effect of metabolic inhibitors on arachidonic acid metabolism in the corneal epithelium: evidence for cytochrome P450-mediated reactions. , 1994, Journal of ocular pharmacology.
[49] M. Jurima‐Romet,et al. Evidence for the catalysis of dextromethorphan O-demethylation by a CYP2D6-like enzyme in pig liver. , 2000, Toxicology in vitro : an international journal published in association with BIBRA.
[50] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[51] J. Prause,et al. Corneal Thickness in Pigs Measured by Ultrasound Pachymetry In Vivo , 2008 .
[52] S. Reichl,et al. mRNA expression of metabolic enzymes in human cornea, corneal cell lines, and hemicornea constructs. , 2012, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[53] P. Friedl,et al. Immortalization of human corneal endothelial cells using electroporation protocol optimized for human corneal endothelial and human retinal pigment epithelial cells. , 2000, Acta ophthalmologica Scandinavica.
[54] K. Tsubota,et al. Corneal damage and lacrimal gland dysfunction in a smoking rat model. , 2011, Free radical biology & medicine.
[55] B. Sjöquist,et al. Ocular and systemic pharmacokinetics of latanoprost in humans. , 2002, Survey of ophthalmology.
[56] D. Greco,et al. Gene expression analysis in SV-40 immortalized human corneal epithelial cells cultured with an air-liquid interface , 2010, Molecular vision.
[57] S Reichl,et al. Human corneal equivalent as cell culture model for in vitro drug permeation studies , 2004, British Journal of Ophthalmology.
[58] N. Burstein,et al. Corneal penetration and ocular bioavailability of drugs. , 1985, Journal of ocular pharmacology.